People who use cholesterol-lowering statins may have a slightly lower risk of developing pneumonia than non-users do, a study out Monday concludes. Israeli researchers found that of nearly 18,000 adults in a clinical trial of rosuvastatin (Crestor), those given the drug were 17 percent less likely to develop pneumonia over several years, versus people given a placebo.
